According to leaked documents from Pfizer, the highest concentrations of lipid nanoparticles of the vaccine in animal models after 2 days were in the following locations: - Injection site: 165 μg/g - Liver: 24.3 - Spleen: 23.4 - Adrenal glands: 18.2 - Ovaries: 12.3

COVID-19 vaccines don’t affect ovaries or fertility in general; the vaccines are highly effective at preventing illness and death healthfeedback.org/claimreview/co… via Health Feedback

Congrats and time to stop saying that MIS is possibly not safe in high risk endometrial cancers! Well done

It is also a risk factor for non-HPV vulvar cancer

The January edition of the RoyalCollegeObsGyn #TheObstetrician&Gynaecologist (TOG) has a great article and infographic on postcoital bleeding by Nick Wood and colleagues - see obgyn.onlinelibrary.wiley.com/doi/epdf/10.11… 📖

"I'm a bit ashamed to admit this, but I was trying to hide the fact that I came from Lebanon." 2021 medicine laureate Ardem Patapoutian (Ardem Patapoutian) shares his personal story of inclusion and how proud he is of his background (something that hasn't always been the case).

⁦Basel_Refky⁩ congratulations

Effect of #HIPEC according to HRD/BRCAwt genomic profile in #OvarianCancer, from the P3 #OVHIPEC trial. Results make no sense... Wim Ceelen Anna Fagotti EVA - Brazilian Gynecologic Oncology Group Peritoneal Surface Oncology Group International Indian society of peritoneal surface malignancy SoMe4Peritoneum pubmed.ncbi.nlm.nih.gov/35583992/

Hugs are the universal medicine

Let’s go! ⁦IGCS⁩ 2022!

😍👏🏻 thank you Audrey Tsunoda & IGCS for the amazing opportunity 🇦🇷🌎 #IGCS2022

Fill Your Soul in Seoul at #IGCS2023! Haneul is the Korean word for “sky.” This is a famous place for the fields of tall pampas grass, sunset views, and night views of Seoul. igcsmeeting.com Reminder: Abstract submission is open!

(⚛️) Espace de sciences : #JamesWebb a découvert des galaxies qui défient les modèles des astronomes ! 🌌 #futurasciences via Futura explore l'espace

MIRASOL trial 🌟453 women w FRa-pos platinum resistant OvCancer 🌟median OS 16.46 mo in Mirvetuximab arm vs 12.75 in chemo-arm,(HR)0.67,p=0.0046 🌟median PFS 5.62 mo vs 3.98,HR 0.65(p<0.0001) 🌟ORR 42.3% vs15.9% Grade 3 TEAEs:42% vs 54% ⁦OncoAlert⁩ cancernetwork.com/view/mirvetuxi…

SHAPE trial results presented at #ASCO2023 supporting safety of less radical surgery in appropriately selected early stage cervical cancer patients with improved quality of life. Less is more.

Yet more showing the benefit of MIS. Nice retrospective analysis. Yes not RCt. But never will there be a RCT of open va MIS for 80+ year olds with endo ca! So don’t even say it

#Mentorship

Last week, the IGCS Board of Directors convened in Chicago to delve deep into the future of our society and the incredible initiatives ahead! 🏙️✨

IGCS and Eisai welcomes you to view "Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications" Industry Supported Symposium presented at the IGCS 2024 Annual Global Meeting in Dublin, Ireland. PART 1:

The last day of the IGCS Annual Global Meeting #IGCS2025 is here! The Phase 3 Hands-on Training Workshop of the IGCS Preinvasive Disease Program has commenced with great talks from faculty. #IGCS2025